Arguing for the motion: Yes, RAGE is a receptor for advanced glycation endproducts

Molecular Nutrition and Food Research

Volumn 51, Issue 9, 2007, Pages 1111-1115

  Ramasamy, Ravichandran ^a   Yan, Shi Fang ^a   Schmidt, Ann Marie ^a,b  

^a NewYork Presbyterian Hospital   (United States)

^b Division of Surgical Science   (United States)

Author keywords

Advanced glycation endproduct; Glycation; RAGE; Receptor; Signal transduction

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; DRUG DERIVATIVE; IMMUNOGLOBULIN RECEPTOR; LYSINE; N(6) CARBOXYMETHYLLYSINE; N(6)-CARBOXYMETHYLLYSINE; UNCLASSIFIED DRUG;

ANIMAL; CATTLE; CHEMISTRY; HUMAN; LUNG; METABOLISM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CATTLE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; LUNG; LYSINE; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION;

EID: 34948829109     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200700008     Document Type: Review

References (40)

1. Schmidt, A. M., Vianna, M., Gerlach, M., Brett, J., et al., Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface, J. Biol. Chem. 1992, 267, 14987-14997.
2. Neeper, M., Schmidt, A. M., Brett, J., Yan, S. D., et al., Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins, J. Biol. Chem. 1992, 267, 14998-15004.
3. Hofmann, M. A., Drury, S., Fu, C., Qu, W., et al., RAGE mediates a novel proinflammatory axis: A central cell surface receptor for S100/calgranulin polypeptides, Cell 1999, 97, 889-901.
4. Hori, O. J., Brett, T., Slattery, R., Cao, J., et al., The Receptor for Advanced Glycation Endproducts (RAGE) is a cellular binding site for amphoterin: Mediation of neunte outgrowth and co-expression of RAGE and amphoterin in the developing nervous system, J. Biol. Chem. 1995, 270, 25752-25761.
5. Taguchi, A., Blood, D. C., del Toro, G., Canet, A., et al., Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases, Nature 2000, 405, 354-360.
6. Yan, S. D., Chen, X., Fu, J., Chen, M., et al., RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease, Nature 1996, 382, 685-691.
7. Yan, S. D., Zhu, H., Zhu, A., Golabek, A., et al., Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis, Nat. Med. 2000, 6, 643-651.
8. Chavakis, T., Bierhaus, A., Al-Fakhri, N., Schneider, D., et al., The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: A novel pathway for inflammatory cell recruitment, J. Exp. Med. 2003, 198, 1507-1515.
9. Schmidt, A. M., Yan, S. D., Brett, J., Mora, R., Stern, D., Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products, J. Clin. Invest. 1993, 92, 2155-2168.
10. Schmidt, A. M., Hori, O., Chen, J., Li, J. F., et al., Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes, J. Clin. Invest. 1995, 96, 1395-1403.
11. Kislinger, T., Fu, C., Huber, B., Qu, W., et al., N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression, J. Biol. Chem. 1999, 274, 31740-31749.
12. Boulanger, E., Grossin, N., Wautier, M. P., Taamma, R., Wautier, J. L., Mesothelial RAGE activation by AGEs enhances VEGF release and potentiates capillary tube formation, Kidney Int. 2007, 71, 126-133.
13. Somoza, V., Lindenmeier, M., Hofmann, T., Frank, O., et al., Dietary bread crust advanced glycation end products bind to the receptor for AGEs in HEK-293 kidney cells but are rapidly excreted after oral administration to healthy and subtotally nephrectomized rats, Ann. N.Y. Acad. Sci. 2005, 1043, 492-500.
14. Lieuw-a-Fa, M. L., Schalkwijk, C. G., Engelse, M., Van Hingsbergh, V. W., Interaction of Nepsilon(carboxymethyl)-lysine- and methylglyoxal-modified albumin with endothelial cells and macrophages. Splice variants of RAGE may limit the responsiveness of human endothelial cells to AGEs, Thromb. Haemost. 2006, 95, 320-328.
15. Wendt, T. M., Tanji, N., Guo, J., Kislinger, T. R., et al., RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy, Am. J. Pathol. 2003, 162, 1123-1137.
16. Flyvbjerg, A., Denner, L., Schrijvers, B. E, Tilton, R. G., et al., Long-term renal effects of a neutralizing RAGE antibody in obese type 2 diabetic mice, Diabetes 2004, 53, 166-172.
17. Yamomoto, Y., Kato, I., Doi, T., Yonekura, H., et al., Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice, J. Clin. Invest. 2001, 108, 261-268.
18. Myint, K. M., Yamamoto, Y., Doi, T., Kato, I., et al., RAGE control of diabetic nephropathy in a mouse model: Effects of RAGE gene disruption and administration of low-molecular weight heparin, Diabetes 2006, 55, 2510-2522.
19. Thallas-Bonke, V., Lindschau, C., Rizkalla, B., Bach, L. A., et al., Attenuation of extracellular matrix accumulation in diabetic nephropathy by the advanced glycation end product cross-link breaker ALT-711 via a protein kinase C-alpha-dependent pathway, Diabetes 2004, 53, 2921-2930.
20. Soulis-liparota, T., Cooper, M., Papazoglou, D., Clarke, B., Jerums, G., Retardation by aminoguanidine of development of albuminurie, mesangial expansion, and tissue fluorescence in streptozocin-induced diabetic rat, Diabetes 1991, 40, 1328-1334.
21. Bierhaus, A., Haslbeck, K. M., Humpert, P. M., Liliensiek, B., et al., Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily, J. Clin. Invest. 2004, 114, 1741-1751.
22. Park, L., Raman, K. G., Lee, K. J., Yan, L., et al., Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts, Nat. Med. 1998, 4, 1025-1031.
23. Bucciarelli, L. G., Wendt, T., Qu, W., Lu, Y., et al., RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice, Circulation 2002, 106, 2827-2835.
24. Bucciarelli, L. G., Kaneko, M., Ananthakrishnan, R., Harja, E., et al., Receptor for advanced-glycation end products: Key modulator of myocardial ischemic injury, Circulation 2006, 113, 1226-1234.
25. Falcone, C., Emanuele, E., D'Angelo, A., Buzzi, M. P., Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men, Arterioscler. Thromb. Vasc. Biol. 2005, 25, 1032-1037.
26. Pullerits, R., Bokarewa, M., Dahlberg, L., Tarkowski, A., Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control, Arthritis Res. Ther. 2005, 7, R817-R824.
27. Emanuele, E., D'Angelo, A., Tomaino, C., Binetti, G., et al., Circulating levels of soluble receptor for advanced glycation end products in Alzheimer disease and vascular dementia, Arch. Neurol. 2005, 62, 1734-1736.
28. Tan, K. C., Shiu, S. W., Chow, W. S., Leng, L. et al., Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes, Diabetologia 2006, 49, 2756-2762.
29. Geroldi, D., Falcone, C., Minoretti, P., Emanuele, E., et al., High levels of soluble receptor for advanced glycation end products may be a marker of extreme longevity in humans, J. Am. Geriatr. Soc. 2006, 54, 1149-1150.
30. Forbes, J. M., Thorpe, S. R., Thailas-Bonke, V., Pete, J., et al., Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy, J. Am. Soc. Nephrol. 2005, 16, 2363-2372.
31. El Khoury, J., Thomas, C. A., Loike, J. D., Hickmann, S., et al., Macrophages adhere to glucose-modified basement membrane collagen IV via their scavenger receptors, J. Biol. Chem. 1994, 269, 10197-10200.
32. Vlassara, H., Li, Y. M., Imani, F., Wojciechowicz, D., et al., Identification of galectin-3 as a high-affinity binding protein for advanced glycation end products (AGE): A new member of the AGE-receptor complex, Molec. Med. 1995, 1, 634-646.
33. Li, Y. M., Mitsuhashi, T., Wojciechowicz, D., Shimizu, N., et al., Molecular identity and cellular distribution of advanced glycation endproduct receptors: Relationship of p60 to OST-48 and p90 to 80K-H membrane proteins, PNAS (USA) 1996, 93, 11047-11052.
34. Ohgami, N., Nagai, R., Ikemoto, M., Arai, H., et al., CD36, serves as a receptor for advanced glycation endproducts (AGE), J. Diabetes Complic. 2002, 16, 56-59.
35. Sakaguchi, T., Yan, S. F., Yan, S. D., Rong, L. L., et al., Central role of RAGE-dependent neointimal expansion in arterial restenosis, J. Clin. Invest. 2003, 111, 959-972.
36. Rong, L. L., Yan, S. F., Wendt, T., Hans-Wagner, D., et al., RAGE modulates peripheral nerve regeneration via recruitment of both inflammatory and oxonal outgrowth pathways, FASEB J. 2004, 18, 1818-1825.
37. Ma, W., Lee, S. E., Guo, J., Qu, W., et al., RAGE ligand upregulation of VEGF in ARPE-19 cells, Invest. Ophthalmol. Vis. Sci. 2007, in press.
38. Obrenovich, M. E., Monnier, V. M., Glycation stimulates amyloid formation, Sci. Aging Knowledge Environ. 2004, 2004, pe3.
39. Yamaguchi, Y., Rauvala, H., Freeze, H. H., N-Glycans on the receptor for advanced glycation end products influence amphoterin binding and neurite outgrowth, J. Neurochem. 2002, 80, 998-1008.
40. Xie, J., Burz, D. S., He, W., Bronstein, I. B., et al., Hexameric calgranulin C (S100A12) binds to the Receptor for Advanced Glycated End Products (RAGE) using symmetric hydrophobic target-binding patches, J. Biol. Chem. 2007, 282, 4218-231.